Cargando…
Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
INTRODUCTION: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resulting in a range of clinical manifestations and outcomes. Laboratory and immunological alterations have been considered as potential markers of disease severity...
Autores principales: | da Silva, Rafaela Pires, Gonçalves, João Ismael Budelon, Zanin, Rafael Fernandes, Schuch, Felipe Barreto, de Souza, Ana Paula Duarte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149905/ https://www.ncbi.nlm.nih.gov/pubmed/34054820 http://dx.doi.org/10.3389/fimmu.2021.657363 |
Ejemplares similares
-
Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
por: Antunes, Krist Helen, et al.
Publicado: (2022) -
Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads
por: Zanin, Natacha, et al.
Publicado: (2021) -
Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure
por: Nagaoka, Kentaro, et al.
Publicado: (2022) -
Kallikrein–Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation
por: Seliga, Alecia, et al.
Publicado: (2018) -
Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue
por: Upasani, Vinit, et al.
Publicado: (2020)